The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.127.8.1009

Therapists who participated in previous active drug-placebo studies of chronic and acute schizophrenics were rated on the Whitehorn-Betz A-B scale. The ratings were then related to treatment outcome. Patients who had been treated with phenothiazines and by Type A (verbal-intellectual) therapists improved more than those treated with placebo and by Type B (practical-mechanical) therapists, although the results were not statistically significant. The authors stress the importance of further research in this area.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.